Breaking News
February 24, 2018 - Will Device Meetings in Europe Suffer Under New Ethics Rule?
February 24, 2018 - Nonstatin drug use increases by 124% in U.S., related expenditures triple
February 24, 2018 - Annual foot screening could help spot heart irregularities in people with diabetes
February 24, 2018 - Researchers developing rapid saliva test to detect Zika virus
February 24, 2018 - For Older Men, Even Light Exercise Helps
February 24, 2018 - Healthy Strategies to Beat Stress
February 24, 2018 - Cancer killing clue could lead to safer and more powerful immunotherapies
February 24, 2018 - Repeated sick days do not affect children’s learning ability, study shows
February 24, 2018 - New two-child policy in China could negatively affect women’s status and gender equality
February 24, 2018 - New research project to determine why mine dust-related lung diseases are on the rise
February 24, 2018 - A Tribute to Dr. Ray Lipicky: The Man Who Transformed Cardiology
February 24, 2018 - ClinicalTrials.gov: Child, Foster
February 24, 2018 - Study shows age doesn’t affect survival in patients with non-Hodgkin lymphoma after HCT
February 24, 2018 - Researchers explore how evolutionary processes guide pathways of cells
February 24, 2018 - Discovery may result in new medication to build stronger muscles in old age
February 24, 2018 - New study identifies possible target for treatment of dangerous allergic reactions
February 24, 2018 - Targeted vaccination can be successful in containing epidemic outbreaks
February 24, 2018 - Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
February 24, 2018 - ‘The Best Deals of Any Payer’: What We Heard This Week
February 24, 2018 - Blood and urine tests developed to indicate autism in children
February 24, 2018 - New low-cost microfluidic device brings single-cell technology to bedside
February 24, 2018 - Covestro and Pittsburgh Penguins announce multi-year unique partnership
February 24, 2018 - Some genes can drive both metastasis and initial stages of tumor growth
February 24, 2018 - Visaris Americas announces installation of fully robotic Vision C digital X-ray suite at OGHS
February 24, 2018 - New discovery could accelerate clinical translation of stem cell-based therapies
February 24, 2018 - Respiratory disease patients with arthritis struggle to use complex inhalers
February 24, 2018 - FDA Alert: Labetalol Hydrochloride Injection by Hospira: Recall
February 24, 2018 - Flu, Tdap Vax Safe for Babies 6 Months Later
February 24, 2018 - Adults with autism show a diminished brain response to hearing their own name
February 24, 2018 - Study provides insight into neurobiology of dying
February 24, 2018 - Study finds tobacco smoke exposure among most adolescents in economically disadvantaged population
February 24, 2018 - U.S. clinical sites evaluating antibody-based therapies to prevent two common bacterial infections
February 24, 2018 - UCLA researchers use fluorescent colored proteins to trace origin of heart cells
February 24, 2018 - UC Riverside researchers discover way to halt cancer metastasis
February 24, 2018 - Home Routines Can Boost a Child’s Readiness for School
February 24, 2018 - FDA Investigating Misuse, Abuse of Gabapentinoids
February 24, 2018 - Scientists find key proteins control risk of osteoarthritis during aging
February 24, 2018 - Izon announce the launch of the qEV2 and qEV10 Exosome Isolation columns
February 24, 2018 - New CSIRO technology can create clean drinking water
February 24, 2018 - Treating sleep-disordered breathing may improve prognosis of heart failure patients
February 24, 2018 - More boys begin school a year late than girls, study finds
February 24, 2018 - Early life exposure to green space could have beneficial effects on cognitive function
February 24, 2018 - Joint Surgery: Aspirin Equals NOAC for Post-Acute VTE Prevention
February 23, 2018 - Scientists identify new marker of arthritis in mice
February 23, 2018 - Beetroot juice supplements may benefit patients with heart failure
February 23, 2018 - New study identifies novel molecular biomarkers of preeclampsia
February 23, 2018 - Researchers discover new link between gut bacteria and obesity
February 23, 2018 - Aimmune Therapeutics’ Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut Allergy
February 23, 2018 - Improving Glaucoma Care: Ophthalmology Times
February 23, 2018 - Preventing dementia: The promising, the disappointing and the inconclusive
February 23, 2018 - Duke researchers show how to retrain immune system of peanut-allergy mice
February 23, 2018 - Older males could live longer with light intensity exercise, study suggests
February 23, 2018 - C-sections and gut bacteria linked to childhood obesity risk
February 23, 2018 - Asthmatics have lower degree of DNA methylation in certain immune cells
February 23, 2018 - Uniforms coated with copper nanoparticles could reduce spread of hospital infections
February 23, 2018 - What Not to Do If You Have Asthma and Want to Get Pregnant
February 23, 2018 - Deep brain stimulation may be promising Alzheimer’s treatment
February 23, 2018 - AMSBIO offers new PARPtrap Assay Kit
February 23, 2018 - New study identifies mechanisms to lengthen egg viability in worms
February 23, 2018 - Interventions to improve self-concept could be critical in treating mental health patients
February 23, 2018 - Few minutes of physical activity may lower risk of death in older men, research suggests
February 23, 2018 - Modifications in HIV test enable rapid detection of Zika virus, study states
February 23, 2018 - Could Hackers Target Heart Devices?
February 23, 2018 - Kids’ Mental Health Status Not a Factor in Gun Storage
February 23, 2018 - Revellers ready for festival drug checks, study finds
February 23, 2018 - Stanford researchers explore how enzyme changes and becomes antibiotic-resistant
February 23, 2018 - Scientists decode molecular structure of healthy huntingtin protein
February 23, 2018 - Efficacy of cancer immunotherapy increased by deactivating tumor defence mechanism
February 23, 2018 - Epigenetic changes due to normal aging process linked to cancer risk
February 23, 2018 - Evaluations of Medicaid experiments by states, CMS are weak, GAO says
February 23, 2018 - Biomarkers ID’d for Anesthesia-Related Neural Damage
February 23, 2018 - Study reveals how kidney disease happens
February 23, 2018 - Iron deficiency early in life can have long-lasting consequences for the brain
February 23, 2018 - High protein diet reduces risk of Alzheimer’s disease, research finds
February 23, 2018 - Research extends powerful capabilities of MRI to nanometer scale
February 23, 2018 - Scientists show that cutting-edge technique can efficiently sort nano-sized particles
February 23, 2018 - Dornier’s new laser innovation delivers confidence to glide through deflected scopes
February 23, 2018 - Neurocrine Biosciences Will File New Drug Application for Opicapone for Parkinson’s Disease Based on Existing Pivotal Clinical Trial Data
February 23, 2018 - Bariatric Surgery Enabled Stopping Diabetes Meds
February 23, 2018 - C-sections and gut bacteria increase risk of childhood obesity
Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions

Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions

image_pdfDownload PDFimage_print
A chest radiograph of a patient with Idiopathic Pulmonary Fibrosis (IPF). Credit: Wikipedia/CC BY-SA 3.0

A study led by investigators at Massachusetts General Hospital (MGH) and University Health Network (UHN) in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis – scarring and excessive tissue deposition that result from abnormal healing responses and can compromise the function of vital organs. In their report that has received advance online publication in Nature Medicine, the researchers describe a series of molecular interactions that are essential for the induction of lung and skin fibrosis in a mouse model and appear to be active in human fibrotic lung disease.

“The ability of organs to regenerate following injury declines with age, so aberrant healing in response to chronic tissue injury in aged individuals can result in fibrosis – which contributes to 45 percent of deaths in the developing world,” explains David Lagares, PhD, director of the Matrix and Mechanobiology Program at the MGH Fibrosis Research Center, co-corresponding author of the report. “Fibrosis is a component of chronic kidney disease, liver cirrhosis and pulmonary fibrosis; and the pathway we have identified could be a therapeutic target for halting the process and for restoring organ function.”

Normal healing requires the interaction of many cell types – immune cells, stem cells, and the connective tissue cells called fibroblasts. Activated fibroblasts are called myofibroblasts and orchestrate many aspects of the healing process. But severe or repetitive injury can cause myofibroblasts to become hyperactive, setting off an out-of-control tissue buildup that leads to fibrosis. The molecular mediators underlying fibroblast activation are poorly understood, and their identification was a primary focus of the current study.

“We specifically wanted to identify factors that could control profibrotic activity without affecting normal wound healing,” says co-corresponding author Mohit Kapoor, PhD, director of Arthritis Research in the Krembil Research Institute at UHN. “Identifying these factors will not only further enhance our understanding of the pathogenesis of fibrosis but will also provide new antifibrotic targets for multiple diseases.”

The investigators first searched a gene expression database for genes that were upregulated in fibroblasts from patients with two important fibrotic diseases – idiopathic pulmonary fibrosis (IPF) and systemic sclerosis or scleroderma – compared with healthy individuals. One of the genes they identified codes for the cell membrane protein ephrin-B2, which binds to receptors on adjacent cells. During normal development ephrin-B2 regulates the formation and assembly of blood vessels, and its activity has been associated with the development of new blood vessels within and around malignant tumors.

After confirming increased ephrin-B2 expression in a set of lung fibroblasts from patients with IPF, the team found that suppressing ephrin-B2 expression blocked the development of lung fibrosis in a mouse model. Further investigation revealed that the attraction of additional fibroblasts to sites of lung injury and their activation into myofibroblasts was set off when the portion of the ephrin-B2 protein that extends outside the cell membrane was clipped off by an enzyme called ADAM10, releasing a molecule called sEphrin-B2.

“Finding that this extracellular portion of ephrin-B2 was cleaved from the cell surface and secreted into the airspace following lung injury was totally unexpected and led us to hypothesize that this soluble form of ephrin-B2 may contribute to lung fibrosis,” says Lagares, a principal investigator in the MGH Division of Pulmonary and Critical Care Medicine and faculty member at Harvard Medical School. “While ephrin-B2 typically interacts with receptors on different types of cells, both ephrin-B2 and its receptors are expressed on the surface of myofibroblasts, where their interaction usually suppresses the process leading to the overaccumulation of fibrotic tissue. In the novel mechanism we have discovered, the release of sEphrin-B2 prevents that inhibitory interaction and activates the receptors, leading to the amplification of tissue fibrosis.”

In their mouse model of lung fibrosis, the inhibition of ADAM10 prevented the shedding of sEphrin-B2 and reduced fibrosis and death. Increased ADAM10-sEphrin-B2 signaling was also found in lung fibroblasts from IPF patients, and the enzyme’s inhibition reduced sEphrin-B2 shedding in cells from both IPF patients and healthy volunteers. Suppression of ADAM10-sEphrin-B2 signaling also reduced the expression of several fibrosis-associated proteins in myofibroblasts from patients with IPF, and levels of sEphrin-B2 were higher in both lung fluid and plasma from patients than from healthy volunteers.

“Myofibroblasts are absent in healthy tissues, but their numbers and activity are markedly increased in fibrotic diseases,” says Kapoor, a senior scientist at UHN. “Our identification of the ADAM10-sEphrin-B2 pathway as a promoter of myofibroblast activation gives us a number of attractive therapeutic targets for pulmonary and other fibrotic diseases.” The team is continuing to investigate the fibrogenic program induced by ephrin-B2 signaling in activated myofibroblasts and testing the potential efficacy of neutralizing ephrin-B2 antibodies in tissue fibrosis.

A guiding force behind this work was the late Andrew Tager, MD, of the MGH Pulmonary and Critical Care Medicine, who founded what is now the Andrew Tager Fibrosis Research Center. “Andy was a giant in pulmonary fibrosis research and one of the most influential scientific minds in the field. His vision and insight were crucial to the discovery of the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis” says Lagares. A co-author of this Nature Medicine paper and an associate professor of Medicine at Harvard Medical School, Tager passed away in August 2017.


Explore further:
Newly identified growth factor inhibitors selectively target the cells that cause fibrosis

More information:
David Lagares et al, ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis, Nature Medicine (2017). DOI: 10.1038/nm.4419

Journal reference:
Nature Medicine

Provided by:
Massachusetts General Hospital

Tagged with:

About author

Related Articles